CFDE Data Portal | Search TZMP1

	Label	Description
	TZMP1 Gene (Entity type)	ENSG00000235453 - transition zone microprotein 1
	GSE217115 3 V 5 ALECTINIB MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE137325 2 V 0 COPANLISIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE82110,GSE82299 1 V 0 ACRIFLAVINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE220520 3 V 4 ETHANOL MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE115550 BRD4 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 3 V 5 GEMCITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE164521 0 V 1 NITRIC OXIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE222676 ABCA1 knockout IMR-90 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

TZMP1

ENSG00000235453 - transition zone microprotein 1

GSE217115 3 V 5 ALECTINIB MOUSE UP

A Gene Set from LINCS

GSE137325 2 V 0 COPANLISIB HUMAN UP

A Gene Set from LINCS

GSE82110,GSE82299 1 V 0 ACRIFLAVINE HUMAN UP

A Gene Set from LINCS

GSE220520 3 V 4 ETHANOL MOUSE DN

A Gene Set from LINCS

GSE115550 BRD4 inhibition 2 v 1 human up

A Gene Set from LINCS

GSE148200 3 V 5 GEMCITABINE HUMAN UP

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 0 v 3 human up

A Gene Set from LINCS

GSE164521 0 V 1 NITRIC OXIDE MOUSE UP

A Gene Set from LINCS

GSE222676 ABCA1 knockout IMR-90 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.